GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnax Lab Ltd (BOM:506128) » Definitions » EV-to-EBIT

Parnax Lab (BOM:506128) EV-to-EBIT : 10.66 (As of Jun. 08, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Parnax Lab EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Parnax Lab's Enterprise Value is ₹1,855 Mil. Parnax Lab's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹174 Mil. Therefore, Parnax Lab's EV-to-EBIT for today is 10.66.

The historical rank and industry rank for Parnax Lab's EV-to-EBIT or its related term are showing as below:

BOM:506128' s EV-to-EBIT Range Over the Past 10 Years
Min: 2.16   Med: 6.29   Max: 27.32
Current: 10.66

During the past 13 years, the highest EV-to-EBIT of Parnax Lab was 27.32. The lowest was 2.16. And the median was 6.29.

BOM:506128's EV-to-EBIT is ranked better than
69.96% of 669 companies
in the Drug Manufacturers industry
Industry Median: 16.7 vs BOM:506128: 10.66

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Parnax Lab's Enterprise Value for the quarter that ended in Mar. 2024 was ₹2,277 Mil. Parnax Lab's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹174 Mil. Parnax Lab's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 7.64%.


Parnax Lab EV-to-EBIT Historical Data

The historical data trend for Parnax Lab's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnax Lab EV-to-EBIT Chart

Parnax Lab Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.63 15.39 11.13 6.58 13.09

Parnax Lab Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.58 3.60 8.82 6.09 13.09

Competitive Comparison of Parnax Lab's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Parnax Lab's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parnax Lab's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnax Lab's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Parnax Lab's EV-to-EBIT falls into.



Parnax Lab EV-to-EBIT Calculation

Parnax Lab's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1855.090/173.954
=10.66

Parnax Lab's current Enterprise Value is ₹1,855 Mil.
Parnax Lab's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹174 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parnax Lab  (BOM:506128) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Parnax Lab's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=173.954/2276.565768
=7.64 %

Parnax Lab's Enterprise Value for the quarter that ended in Mar. 2024 was ₹2,277 Mil.
Parnax Lab's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹174 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parnax Lab EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Parnax Lab's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Parnax Lab (BOM:506128) Business Description

Traded in Other Exchanges
N/A
Address
104 - 107, Building No. 8, Gala No. 114, Jogani Industrial Complex, Panchsheel Nagar, Next to Modi Hyundai Service Centre, Chunabhatti, Sion, Mumbai, MH, IND, 400 022
Parnax Lab Ltd is principally engaged in the manufacturing and export of Pharmaceutical Formulations. Its product categories include Pharmaceuticals; Cosmetics; Herbal and Nutraceuticals. The company is developing and delivering Oral Formulations such as Cough Expectorants, Antacids, Anti-Histamines, Multi-Vitamins, Enzyme Preparations, Pediatric Formulations, Special Formulations for Geriatrics, Highly Viscous Products, Suspensions, and others.

Parnax Lab (BOM:506128) Headlines

No Headlines